Amy Edmonds

Amy Edmonds has extensive work experience in the clinical operations field. Amy is currently the Vice President, Global Head Clinical Operations at Achilles Therapeutics plc, a position they have held since August 2022. Prior to this, they were the Vice President, Clinical Operations at the same company from November 2021 to July 2022.

Before joining Achilles Therapeutics plc, Amy held various positions at Bellerophon Therapeutics, starting as a Manager in Clinical Operations and eventually becoming the Vice President of Clinical Operations and Administration. Amy'stenure at Bellerophon lasted from February 2014 to November 2021.

Amy also worked at IKARIA, Inc., where they served as the Senior Director of Clinical Operations and later took on additional responsibilities in strategic outsourcing and clinical site contracts. Amy'stime at IKARIA spanned from September 2012 to February 2014.

Prior to IKARIA, Inc., Amy held the position of Director of Clinical Monitoring - Americas at Celgene Corporation. Amy also worked at Celgene in various roles, including Associate Director of Clinical Operations - Americas, Senior Manager of Clinical Operations, and Manager of Clinical Operations, from 2002 to 2012.

Amy'searly career included positions at Pfizer, Knoll, ICON plc, and Beardsworth Consulting Group, where they gained experience as a Manager in education and operations, Manager in clinical operations and training, Senior Training Specialist, and Clinical Research Associate, respectively.

Overall, Amy Edmonds has a wealth of experience in clinical operations, with a focus on managing and overseeing various aspects of clinical trials and operations at several pharmaceutical companies.

Amy Edmonds received a Bachelor's degree in Science and Sociology from the University of Richmond, completing their studies between 1990 and 1994. There is no further information provided regarding their education history.